First Time Loading...

RVL Pharmaceuticals PLC
NASDAQ:RVLP

Watchlist Manager
RVL Pharmaceuticals PLC Logo
RVL Pharmaceuticals PLC
NASDAQ:RVLP
Watchlist
Price: 0.0024 USD 14.29%
Updated: May 7, 2024

RVL Pharmaceuticals PLC
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

RVL Pharmaceuticals PLC
Net Income (Common) Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
RVL Pharmaceuticals PLC
NASDAQ:RVLP
Net Income (Common)
-$51.7m
CAGR 3-Years
42%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Income (Common)
$38.5B
CAGR 3-Years
37%
CAGR 5-Years
21%
CAGR 10-Years
10%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income (Common)
-$6.1B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income (Common)
-$309m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income (Common)
$2.3B
CAGR 3-Years
-31%
CAGR 5-Years
-23%
CAGR 10-Years
-7%
Eli Lilly and Co
NYSE:LLY
Net Income (Common)
$6.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
5%

See Also

What is RVL Pharmaceuticals PLC's Net Income (Common)?
Net Income (Common)
-51.7m USD

Based on the financial report for Dec 31, 2022, RVL Pharmaceuticals PLC's Net Income (Common) amounts to -51.7m USD.

What is RVL Pharmaceuticals PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-5%

Over the last year, the Net Income (Common) growth was 20%. The average annual Net Income (Common) growth rates for RVL Pharmaceuticals PLC have been 42% over the past three years , -5% over the past five years .